| abstract |
This invention provides a cardiac rehabilitation agent comprising at least one species of the class consisting of purine nucleoside and purine nucleotide, e.g. a composition comprising inosine, cytidine, uridine, a salt of guanosine 5'-monophosphate, and thymidine in a molar ratio of 4:4:3:4:1. The cardiac rehabilitation agent of this invention is characterized by excellent cardiac function-restorative activity and no risk of side effect. |